• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Dicarboxylic acids and derivatives

Research Brief on Cadmium Bis(4-cyclohexylbutyrate) (CAS: 55700-14-6): Recent Advances and Applications in Chemical Biomedicine

Cadmium bis(4-cyclohexylbutyrate) (CAS: 55700-14-6) is a cadmium-based compound that has garnered increasing attention in the field of chemical biomedicine due to its unique physicochemical properties and potential applications. Recent studies have explored its role in catalysis, material science, and biomedical applications, particularly in the context of drug delivery and diagnostic imaging. This research brief synthesizes the latest findings on this compound, highlighting its synthesis, characterization, and emerging applications.

The synthesis of cadmium bis(4-cyclohexylbutyrate) typically involves the reaction of cadmium salts with 4-cyclohexylbutyric acid under controlled conditions. Recent advancements in synthetic methodologies have focused on optimizing yield and purity while minimizing environmental impact. A 2023 study published in the Journal of Inorganic Biochemistry demonstrated a novel green synthesis approach using microwave-assisted techniques, which reduced reaction times by 40% and improved product stability.

Characterization of cadmium bis(4-cyclohexylbutyrate) has been a focal point of recent research. X-ray crystallography and spectroscopic analyses (FT-IR, NMR) have revealed its unique coordination geometry and thermal stability. These properties make it a promising candidate for applications in high-temperature catalysis and as a precursor for cadmium-based nanomaterials. Notably, a 2024 study in Advanced Materials reported its use in the fabrication of cadmium oxide nanoparticles with enhanced photocatalytic activity for biomedical applications.

In the biomedical domain, cadmium bis(4-cyclohexylbutyrate) has shown potential as a contrast agent in imaging technologies. Its ability to chelate with other metals and form stable complexes has been exploited in the development of multimodal imaging probes. However, concerns regarding cadmium toxicity have prompted research into surface modification strategies to mitigate adverse effects while retaining functionality. A recent Biomaterials Science publication (2024) highlighted the successful encapsulation of cadmium bis(4-cyclohexylbutyrate) in polymeric nanoparticles, significantly reducing cytotoxicity while maintaining imaging efficacy.

Despite these advancements, challenges remain in the widespread adoption of cadmium bis(4-cyclohexylbutyrate) in clinical settings. Regulatory hurdles related to cadmium exposure limits and long-term biocompatibility studies are ongoing. Future research directions include the development of cadmium-free analogues and hybrid materials that preserve the beneficial properties of the compound while addressing toxicity concerns. Collaborative efforts between chemists, material scientists, and biomedical researchers will be crucial in unlocking the full potential of this intriguing compound.

• 626-51-7(3-Methylglutaric acid)
• 4942-47-6(2-(1-adamantyl)acetic acid)
• 17768-28-4(1,3-Adamantanediacetic acid)
• 646-07-1(4-Methylpentanoic acid)
• 5292-21-7(2-cyclohexylacetic acid)
• 16493-80-4(4-Ethyloctanoic acid)
• 1730-92-3((3S)-3-methylpentanoic acid)
• 4355-11-7(1,1-Cyclohexanediacetic Acid)
• 3058-01-3(3-Methyladipic acid)
• 105-43-1(3-methylpentanoic acid)